| Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses S Das, E Sarrou, S Podgrabinska, M Cassella, SK Mungamuri, N Feirt, ... Journal of Experimental Medicine 210 (8), 1509-1528, 2013 | 192 | 2013 |
| Lymphatic vessel activation in cancer S Das, M Skobe Annals of the New York Academy of Sciences 1131 (1), 235-241, 2008 | 110 | 2008 |
| Optimization of the transductional efficiency of lentiviral vectors: effect of sera and polycations W Denning, S Das, S Guo, J Xu, JC Kappes, Z Hel Molecular Biotechnology 53 (3), 308-314, 2013 | 95 | 2013 |
| Cell-based approach for 3D reconstruction of lymphatic capillaries in vitro reveals distinct functions of HGF and VEGF-C in lymphangiogenesis L Gibot, T Galbraith, B Kloos, S Das, DA Lacroix, FA Auger, M Skobe Biomaterials 78, 129-139, 2016 | 91 | 2016 |
| Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases S Das, DS Ladell, S Podgrabinska, V Ponomarev, C Nagi, JT Fallon, ... Cancer research 70 (5), 1814-1824, 2010 | 63 | 2010 |
| High endogenous CCL2 expression promotes the aggressive phenotype of human inflammatory breast cancer SAA Anita Rogic, Ila Pant, Luca Grumolato, Ruben Fernandez-Rodriguez, Andrew ... Nature Communications 12 (1), 2021 | 30 | 2021 |
| Involvement of NKR‐P2/NKG2D in DC‐mediated killing of tumor targets: indicative of a common, innate, target‐recognition paradigm? R Alli, B Savithri, S Das, C Varalakshmi, N Rangaraj, A Khar European journal of immunology 34 (4), 1119-1126, 2004 | 30 | 2004 |
| Role of STAT3 and NFκB signaling in the serum factor-induced apoptosis in AK-5 cells AL Kumari, AM Ali, S Das, BVV Pardhasaradhi, CH Varalakshmi, A Khar Biochemical and biophysical research communications 336 (3), 860-867, 2005 | 16 | 2005 |
| Target cell induced activation of NK cells in vitro: cytokine production and enhancement of cytotoxic function S Das, C Varalakshmi, LA Kumari, M Patel, A Khar Cancer Immunology, Immunotherapy 50, 428-436, 2001 | 13 | 2001 |
| Regulation of NK cell function in vivo by the dose of tumour transplanted in the peritoneum S Das, A Khar Immunology letters 83 (2), 133-142, 2002 | 11 | 2002 |
| Target-cell-induced anergy in natural killer cells: suppression of cytotoxic function S Das, C Varalakshmi, A Khar Cancer Immunology, Immunotherapy 49, 109-115, 2000 | 9 | 2000 |
| Blocking Angiopoietin-2 promotes vascular damage and growth inhibition in mouse tumors treated with small doses of radiation P Kallio, E Jokinen, J Högström, S Das, S Heino, M Lähde, J Brodkin, ... Cancer Research 80 (12), 2639-2650, 2020 | 6 | 2020 |
| Examination of lymphatic system S Das Clinical Surgery 4, 86-87, 2010 | 6 | 2010 |
| Active lymph nodes GK Alderton Nature Reviews Cancer 13 (9), 607-607, 2013 | 3 | 2013 |
| Patent: Compositions and methods comprising vegfr-2 and vegfr-3 antagonists for the treatment of metastatic disease M Skobe, S Das US Patent App. 13/322,447, 2012 | 1* | 2012 |
| Modeling Effects of Chemotherapeutics on Metastases in the Lymphatic Vessels RE Griswold, S Das, S Cho, BE Griffith, S Podgrabinska, J Gallo, ... JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS 41, S34-S35, 2014 | | 2014 |
| Function of chemokine receptor ccr8 in melanoma metastasis M Skobe, S Das | | 2013 |
| Patent: Function of chemokine receptor ccr8 in melanoma metastasis M Skobe, S Das | | 2013 |
| Triple antibiotics: A synergistic approach to combating infection A Kumari, H Sawhney, R Kashwani, G Gupta, SJ Das | | |
Dr. Sathish Kumar MungamuriIndian Council of Medical Research - National Institute of NutritionVerified email at icmr.gov.in
